We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Cancer Cells Switch Sugar for Fatty Acids to Spread Around the Body

News

Scientists have uncovered a crucial change in cancer cells that allows them to spread around the body – by switching from sugar to fatty acids to fuel their growth.

READ MORE

Anticancer Drug Disguises Itself As Fat

News

A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors.

READ MORE

Large Study Suggests Nutrient Supplements Don’t Improve Heart Health or Put Off Death

News

In a massive new analysis of findings from 277 clinical trials using 24 different interventions, researchers say they have found that almost all vitamin, mineral and other nutrient supplements or diets cannot be linked to longer life or protection from heart disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE